Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUTOX: Glutamine and Ca-Mg for Oxaliplatin-Induced Neurotoxicity
NCT01087658Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in peripheral sensory neuropathy, sponsored by Sanofi. Started Feb 2010; status: completed.
02
Drugs
glutamine
03
Conditions
peripheral sensory neuropathy
Beyond the preview
Go deeper on NCT01087658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087658.